Related Experiment Videos
Ovarian volume and PCOS: a controversial issue
Pierluigi Giampaolino1, Luigi Della Corte2, Nicoletta De Rosa2
1a Department of Public Health , University of Naples Federico II , Naples , Italy.
Summary
Ovarian volume does not predict clomiphene citrate (CC) ovulation success in women with PCOS phenotype 2 (anovulation + hyperandrogenism). This finding is crucial for tailoring CC ovulation induction therapy.
Area of Science:
- Reproductive Endocrinology
- Gynecology
- Clinical Andrology
Background:
- Polycystic ovarian syndrome (PCOS) is a common endocrine disorder with four phenotypes.
- Ovarian morphology, specifically ovarian volume, may influence ovulation induction therapy.
- Previous studies suggest an inverse relationship between ovarian volume and clomiphene citrate (CC) sensitivity in certain PCOS phenotypes.
Purpose of the Study:
- To investigate the impact of ovarian volume on CC ovulation induction success rates.
- To evaluate if ovarian volume predicts the required CC dosage in women with PCOS phenotype 2 (anovulation + hyperandrogenism).
Main Methods:
- Retrospective study of 80 women with PCOS phenotype 2.
- Patients stratified by CC dosage (50mg, 100mg, 150mg) and treatment response.
- Statistical analysis to assess correlation between ovarian volume and ovulation rates.
Main Results:
- Overall, 72.5% of women (58/80) achieved ovulation.
- No significant correlation found between ovarian volume and ovulation chance with increasing CC dosage.
- Ovarian volume was similar in both CC responders and non-responders.
Conclusions:
- Ovarian volume does not predict CC ovulation induction success in PCOS phenotype 2.
- Ovarian volume has no predictive value for the dosage of CC required to induce ovulation in this specific PCOS phenotype.